The US Food and Drug Administration (FDA) has awarded a pre-market supplemental approval (PMA) to Paradigm Spine’s disposable instrument set for its Class III spinal device.

The coflex Interlaminar Stabilization device is understood to be the first spinal instrument to obtain FDA approval.

Paradigm Spine said that its kit is a posterior lumbar motion preservation solution and demonstrated long-term outcomes for patients suffering from moderate to severe spinal stenosis.

The simplified set will comprise injection moulded instruments in a pre-sterilised peel pack. It comes with a future option for implantation of coflex that is considered effective in the outpatient care setting.

“These kits are simple, disposable, sterile, and will reduce both financial and operational burdens on facilities.”

Paradigm Spine chairman and CEO Marc Viscogliosi said: “We are thrilled to have the first PMA-approved disposable instrument kit for a Class III spinal device, and be able to offer this resource to our surgeon customers, further improving their experience with coflex.

“These kits are ideal for outpatient and ambulatory surgery centres because they are simple, disposable, sterile, and will reduce both financial and operational burdens on facilities.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“In addition, through a more streamlined manufacturing process, the kits are created to have a low carbon footprint, so they benefit physicians without causing excessive harm to the environment.”

Lumbar spinal stenosis, which affects 1.6 million people in the US each year, is a debilitating and degenerative condition characterised by leg and back pain, leg numbness and weakness.

The disease is usually treated through surgical decompression alone or in combination with lumbar fusion.